Biosensing Techniques in Yeast: G-Protein Signaling and Protein-Protein Interaction Assays for Monitoring Ligand Stimulation and Oligomer Formation of Heterologous GPCRs by Nakamura, Yasuyuki et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 3
Biosensing Techniques in Yeast: G-Protein Signaling
and Protein-Protein Interaction Assays for Monitoring
Ligand Stimulation and Oligomer Formation of
Heterologous GPCRs
Yasuyuki Nakamura, Akihiko Kondo and Jun Ishii
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.76330
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
i  , i i     J  Is ii
iti al i f r ati  is availa le at t e e  f t e c a ter
Abstract
Guanine nucleotide-binding proteins (G-proteins) act as transducers of external stimuli 
for intracellular signaling, and control various cellular processes in cooperation with 
seven transmembrane G-protein-coupled receptors (GPCRs). Because GPCRs constitute 
the largest family of eukaryotic membrane proteins and enable the selective recognition 
of a diverse range of molecules (ligands), they are the major molecular targets in pharma-
ceutical and medicinal fields. In addition, GPCRs have been known to form heteromers 
as well as homomers, which may result in vast physiological diversity and provide 
opportunities for drug discovery. G-proteins and their signal transduction machinery 
are universally conserved in eukaryotes; thereby, the yeast Saccharomyces cerevisiae has 
been used to construct artificial in vivo GPCR biosensors. In this chapter, we focus on the 
yeast-based GPCR biosensors that can detect ligand stimulation and oligomer forma-
tion, and summarize their techniques using the G-protein signaling and protein-protein 
interaction assays.
Keywords: yeast, G-protein, G-protein-coupled receptor, signal transduction, oligomer 
formation, reporter gene assay, protein-protein interaction
1. Introduction
Guanine nucleotide-binding proteins (G-proteins) are highly conserved among various 
eukaryotes, and act as signal transduction molecules [1, 2]. In cooperation with seven 
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transmembrane G-protein-coupled receptors (GPCRs), G-proteins transduce external 
stimuli to intracellular signaling and control a wide variety of cellular processes. GPCRs, 
which represent the largest family of integral membrane proteins and present more than 
800 genes in the human genome [3], engage a wide range of ligands. GPCR ligands range 
from small molecules to large proteins, such as hormones, neurotransmitters, ions, tas-
tants, odor molecules and even light [4]. Thus, GPCRs are involved in various physiologi-
cal processes, and are the targets of several prescribed drugs [5–8].
Agonist ligand binding to a GPCR causes ligand-specific active conformational changes, and 
allows the receptor to couple to G-proteins that are composed of Gα, Gβ and Gγ subunits [9]. 
Subsequently, heterotrimeric G-proteins dissociate from the receptor, and then G-protein sig-
naling generates second messengers such as cyclic adenosine monophosphate (cAMP), inosi-
tol phosphates, and intracellular Ca2+. These second messengers trigger different cellular and 
ultimately physiological responses [10]. During these processes, G-proteins switch from an 
inactive state to an active state by exchanging a guanosine diphosphate (GDP) molecule from 
the Gα subunit for guanosine triphosphate (GTP). To resume an inactive state, G-proteins 
hydrolyze GTP to GDP [11].
Historically, GPCRs transduce signals only as single monomeric entities (homomers) [12]. 
However, in the past two decades, several studies have shown that GPCRs also transduce 
signals as heteromers [13–18]. Heteromerization is involved in both the regulation and 
modulation of GPCR signaling, consequently increasing the potentially large functional and 
physiological diversity of various GPCR-mediated processes (e.g., ligand binding, receptor 
biosynthesis, cellular trafficking, maturation, G-protein activation, and internalization) [19–
24]. Therefore, heteromerization among GPCRs may provide new opportunities for drug dis-
covery [25, 26]. For example, GPCR heteromers may be new molecular targets for therapeutic 
treatments, or for developing more potent and selective compounds, such as bispecific or 
bivalent ligands, with reduced side effects [27–29]. The mechanism of GPCR heteromerization 
has been under debate, because the identification of individual heteromer pairs is ongoing 
and the in vivo physiological importance of heteromerization has not been well explored. 
Thus, the search for functional GPCR oligomer pairs is still a challenging task, due to the 
continued need for elucidation of their physiological roles.
Saccharomyces cerevisiae is an extremely simplistic unicellular eukaryote and an excellent host 
system for investigating both GPCR signaling and GPCR oligomerization, as the simplicity of 
this fungus allows for simplified analyses of the more complicated mammalian GPCR signaling 
[30]. For instance, since haploid yeast cells harbor a monopolistic G-protein (pheromone) sig-
naling pathway, and experience a variety of heterologous GPCR expressions, yeast cells have 
often been utilized for studies of human and other mammalian GPCRs such as: identification 
of agonistic ligands, analysis of ligand-mediated signaling properties, and mutational analysis 
of critical amino acid residues [30–32]. Additionally, yeast two-hybrid (Y2H) techniques can 
be utilized to investigate exhaustive protein interaction pairs [30], in which the split-ubiquitin 
membrane Y2H (mY2H) system is suitable for screening membrane protein interaction part-
ners [33] including GPCR heteromer pairs [34]. In this chapter, we focus on yeast-based bio-
sensors that detect ligand stimulation and oligomer formation of GPCRs, and summarize their 
techniques using the G-protein signaling and protein-protein interaction assays.
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2. G-protein signaling
Heterotrimeric G-proteins, as peripheral membrane proteins, interact with the plasma mem-
brane on the cytoplasmic side. G-proteins consist of three subunits, Gα, Gβ, and Gγ, which 
are widely conserved in eukaryotic species, and there are various subfamilies within each 
subunit, especially the Gα subunit. The heterotrimeric G-proteins transduce messages from 
GPCRs, which regulate important functions such as vision, taste, smell, heart rate, blood 
pressure, neurotransmission, cell growth, and numerous other processes [10, 35]. When, in 
response to extracellular stimuli, GPCRs transduce ligand-specific intracellular signaling cas-
cades, they activate a GDP to GTP exchange on the Gα subunit, resulting in Gα dissociation 
from the Gβγ complex. Free Gα or Gβγ interacts with several downstream effectors including 
phospholipases, adenylyl cyclases, phosphodiesterases, tyrosine kinases, ion channels, and 
ion transporters in human and other mammalian cells [36, 37].
2.1. Heterotrimeric G-protein signaling in yeast
S. cerevisiae’s pheromone-based mating response provides a valuable model system for 
characterization of G-protein-mediated GPCR signaling (Figure 1) [38], because it allows for 
simplified analyses of the more complicated signaling pathways employed by higher eukary-
otic cells [30]. The yeast pheromone signaling pathway is non-competitive and monopo-
listic, unlike other higher eukaryotes, and is mediated by a sole heterotrimeric G-protein 
comprising three subunits, a Gα subunit (Gpa1p) and the Gβγ complex (Ste4p − Ste18p) 
[39]. Haploid yeast cells of mating type a (MATa) express Ste2p, which binds the peptide 
pheromone α-factor secreted by cells of the opposite mating type (MATα). Upon phero-
mone binding, Ste2p undergoes a conformational change and induces a guanine-nucleotide 
exchange on Gpa1p [40]. Replacement of GDP with GTP on Gpa1p causes a dissociation of 
the Ste4p − Ste18p complex. Ste4p facilitates binding of the dissociated Ste4p − Ste18p com-
plex to effectors, and results in activation of the mitogen-activated protein kinase (MAPK) 
cascade [41, 42]. Ste5p scaffold protein binds to the components of a MAPK cascade to bring 
them to the plasma membrane, and the concentrated kinases on the membrane may facili-
tate amplification of the signal [43, 44]. As a consequence, the activated yeast pheromone 
signaling leads to phosphorylation of the cyclin-dependent kinase inhibitor Far1p and the 
transcription factor Ste12p. These phosphorylated proteins induce G1 cell cycle arrest [45–
47] and global changes in transcription [48, 49]. For example, FUS1 gene expression experi-
ences drastic transcriptional changes in response to yeast pheromone signaling [50, 51]. The 
FIG1 gene is also a mating-specific Ste12p target gene [52, 53]. Sst2p is one of the main nega-
tive regulators of the yeast pheromone pathway [54] and acts as a GTPase-activating protein 
(GAP), enhancing the rate of Gα-catalyzed GTP hydrolysis [55–57]. GDP-bound Gα rapidly 
reassociates with the Gβγ complex, inactivating the pheromone response.
The yeast S. cerevisiae is amenable for reporter gene assays investigating agonist-stimulated 
G-protein signaling. Briefly, yeast cells become available to detect signaling through endoge-
nous or heterologously expressed GPCRs by putting reporter genes, such as HIS3 (detected by 
complementation of auxotrophy), lacZ (detected by colorimetry), luc (detected by luminometry) 
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 and gene encoding green fluorescent protein (GFP) (detected via fluorescence), under the expres-
sion control of a pheromone-responsive promoter like FUS1 or FIG1 [58–60].
2.2. Improvement of the sensitivity of the yeast G-protein signaling
To increase the sensitivity of human GPCR expressing yeast cells, several modifications 
of yeast-based biosensors have been reported. The yeast’s single GPCR (yeast pheromone 
receptor Ste2p) is often deleted to avoid competitive expression with heterologous GPCRs 
Figure 1. Overview of the yeast pheromone signaling pathway and the human GPCR-expressing yeast signaling biosensor. 
(A) Schematic illustration of the pheromone signaling pathway. The pheromone signaling pathway is activated, via the 
heterotrimeric G-protein, when α-factor binds to the Ste2p receptor. The effectors and kinases constitute that MAPK 
cascades are activated by sequestered Ste4p − Ste18p complex from Gpa1p. Sst2p stimulates hydrolysis of GTP to GDP on 
Gpa1p and helps to inactivate pheromone signaling. (B) Schematic illustration of typical genetic modifications enabling 
the pheromone signaling pathway to be used as a biosensor for GPCR activation. Chimeric Gpa1/Gα (transplant) can 
help to transduce the signal from human GPCRs expressed on the yeast plasma membrane. Transcription machineries, 
closely regulated by the phosphorylated transcription factor Ste12p, are used to detect activation of pheromone signaling 
with various reporter genes. SST2, FAR1, and STE2 genes are often disrupted to improve ligand sensitivity, prevent 
growth arrest (cell cycle arrest), and avoid competitive expression of the yeast endogenous receptor.
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[30]; therefore, expressing human GPCR on the plasma membrane of ste2Δ a-cells harboring 
reporter genes facilitates the monitoring of agonist-promoted signaling [30, 61]. The yeast 
G1-cyclin-dependent kinase inhibitor Far1p, which induces G1 cell cycle arrest in response to 
signaling, is usually disrupted in positive selection screening to avoid abnormal cell growth 
[30], because the far1Δ strain continues cell growth and improves plasmid retention rates [62]. 
Removing Sst2p facilitates experiments requiring high ligand binding sensitivity [30, 31, 63], 
as this removal results in a significant decrease in Gpa1p’s GTPase activity by inhibiting the 
conversion of GTP to GDP.
Yeast Gpa1p is equivalent to mammalian Gα. Gpa1p shares particularly high homology with 
the human Gα
i
 classes, and GPCRs from a variety of species, including human, are able to 
both interact with Gpa1p and activate yeast pheromone signaling [32, 64, 65]. Various genetic 
modifications allow many other human GPCRs to function as yeast signaling modulators. 
In one such modification, a chimeric Gpa1p system, referred to ‘as “transplants”, has’ been 
employed to substitute only five Gpa1p C-terminus amino acids for those of human Gα sub-
units, of which there are three key families: Gα
i/o
, Gα
s
, and Gα
q
 [66]. Indeed, these transplants 
have allowed functional coupling of various GPCRs (including serotonin, purinergic, mus-
carinic, and many other receptors) to the yeast pheromone pathway with greater coupling 
efficiency [32, 66–68].
The use of fluorescent reporter genes can provide the most simple and convenient proce-
dure for comparative quantification of signaling levels, as this removed the need for labo-
rious operations such as sample preparations and enzyme reactions. GFP is commonly 
chosen as the fluorescent reporter and enhanced green fluorescent protein (EGFP) is often 
utilized as the GFP. However, the EGFP gene was originally codon-optimized for mamma-
lian cells, and it was not suitable for expression in yeast cells [69]. To increase the maximum 
expression level of GFP and decrease the detection limit of signaling, Nakamura et al. used 
the tetrameric Zoanthus sp. green fluorescent protein (ZsGreen) as a reporter [70]. The use 
of the ZsGreen reporter gene exhibited extremely bright fluorescence and a high signal-to-
noise (S/N) ratio in yeast, showing a dramatic improvement in both brightness and sen-
sitivity for GPCR signaling assays compared to a fluorescence reporter system using the 
EGFP reporter gene [70].
2.3. Detection of GPCR agonists by utilizing yeast G-protein signaling
Many heterologous GPCRs (including muscarinic, neurotensin, serotonin, somatosta-
tin, adrenergic, olfactory, and many other receptors) have been functionally expressed in 
yeast, successfully demonstrating the feasibility of yeast-based GPCR biosensors [31, 32, 
63–67, 71–73].
For example, the cyclic neuropeptide somatostatin, known to inhibit growth hormone release, 
regulates the human endocrine system through somatostatin receptor (SSTR) binding. There 
are five identified SSTR subtypes (SSTR1 − SSTR5) [74, 75]. SSTR2 and SSTR5 are known 
to regulate acromegaly patient growth hormone secretion, and are also expressed in most 
growth hormone secreting tumors [76]. Several researchers demonstrated functional expres-
sion of human SSTR2 and SSTR5 in yeasts, and SSTR5 has been often used for constructing 
yeast-based somatostatin-specific biosensors. To modify the functional expression of human 
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SSTR5 and somatostatin-specific signaling functions in yeasts, addition of signal sequences 
derived from secretion or membrane proteins (e.g., prepro- and pre-regions of α-factor, 
and a N-terminal 20 amino acids of yeast Ste2p; Ste2N) to the N-terminus of the receptor, 
and implementation of the chimeric Gpa1/Gα
i3
 transplant (see Section 2.2) were tested [77]. 
Additionally, the GFP reporter gene assay (see Section 2.1) was used for evaluating the func-
tional expression of SSTR5 and the signaling response to somatostatin binding. Through 
these evaluations, yeast cells with improved capabilities as a biosensor capable of detect-
ing somatostatin-promoted signaling (such as potency and efficacy) were successfully con-
structed. Using this yeast-based biosensor, Togawa et al. performed site-directed mutagenesis 
of human SSTR5, showing the importance of two asparagine residues (Asn13 and Asn26) on 
the N-linked glycosylation motifs for signaling activation [78]. Furthermore, the artificial sig-
naling circuit formulated a positive feedback loop using Gβ (Ste4p; artificial signal activator, 
which was set downstream the pheromone-responsive promoter), and was demonstrated to 
enable highly sensitive agonist detection in SSTR5 expressing yeast [79].
Neurotensin receptor type-1 (NTSR1), a member of the GPCR family, is another example 
of site-directed mutagenesis of human SSTR5. Neurotensin is the natural ligand of NTSR1, 
as well as a central nervous system neuromodulator [80]. As neurotensin is also involved in 
many oncogenic events [81], NTSR1 is a significant therapeutic target. To monitor the acti-
vation of human NTSR1 signaling responding to its agonist, a fluorescence-based microbial 
S. cerevisiae-based biosensor was constructed [82]. Successful detection of NTSR1 signaling 
responding to agonistic ligands was achieved in the Gα-engineered yeast strains IMFD-72 
and IMFD-74, which were generated by substituting the Gpa1/Gα
i3
 and Gpa1/Gα
q
 transplants 
for the intact Gpa1p in modified yeast IMFD-70 strain (ste2Δ, sst2Δ, far1Δ, P
FIG1
-EGFP x2) [82]. 
EGFP genes on the genomes of IMFD-70 and IMFD-72 were replaced with ZsGreen genes 
to generate IMFD-70ZsD and IMFD-72ZsD strains, resulting in the drastic improvement in 
bright fluorescence and high S/N ratio in the NTSR1 signaling assay [70]. Recently, Hashi 
et al. modified the expression modes of the human NTSR1 receptor by altering the promoter, 
consensus Kozak-like sequence, and secretion signal sequences of the receptor-encoding gene 
[83]. The resulting yeast cells exhibited increased sensitivity to exogenously added neuroten-
sin [83].
Angiotensin II (Ang II) type 1 receptor (AGTR1) is also a GPCR and its natural ligand, Ang 
II, is an important effector molecule for the renin-angiotensin system. Thus, AGTR1 controls 
blood pressure and volume in the cardiovascular system [84, 85]. Interaction of Asn295 with 
Asn111 may play a role in determining the ligand peptide binding selectivity of AGTR1 
receptors [86, 87]. Therefore, a single alanine or serine mutation was introduced at Asn295 of 
human AGTR1, and the Asn295-mutated (N295A and N295S) AGTR1 was expressed in the 
IMFD-72ZsD yeast strain [88]. When exposed to Ang II and Ang II peptidic analogs, which 
differ in affinity toward AGTR1, these cells resulted in successful signal transmissions inside 
the yeast cells. Additionally, the secretory expression plasmids for angiotensin peptides 
(Ang II, Ang III, and Ang IV) were transformed into the yeasts expressing AGTR1-N295A or 
AGTR1-N295S, showing the ZsGreen fluorescence with different intensities according to the 
respective agonistic activities. In contrast, the monoamine neurotransmitter serotonin (5-HT) 
regulates a wide spectrum of human physiology through the 5-HT receptor family [89]. 
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Nakamura et al. expressed the human HTR1A in the IMFD-72ZsD strain to enable improved 
detection of HTR1A signaling in response to the 5-HT [90]. The authors further validated the 
capability of this improved yeast biosensor for antagonistic ligand characterization and site-
directed mutants of human HTR1A.
The rat M
3
 muscarinic acetylcholine receptor (M3R) has been used for rapid identification 
of functionally critical amino acids with random mutagenesis [67]. In this system, the CAN1 
gene coding for arginine-canavanine permease was used as the reporter gene under the con-
trol of a pheromone responsive FUS2 promoter, and in the endogenous CAN1-deleted yeast 
cells. Owing to the cytotoxicity of canavanine, caused by Can1p expression in response to pro-
moted signaling, recombinant strains with inactivation mutations in the M3R receptor could 
survive on agar media containing canavanine and M3R-specific agonists. In another study, 
using this yeast platform, “antagonists” atropine and pirenzepine were found to be inverse 
agonists and low efficacy agonists when coupled to Gpa1/Gα
q
 and Gpa1/Gα
12
, respectively 
[91]. In an extended study, the applicability of this yeast platform to identify allosteric ligand-
mediated functional G-protein selectivity was also tested [92].
Human formyl peptide receptor-like 1, which was originally identified as an orphan GPCR, 
has been used to isolate agonists for functionally unknown GPCRs [93]. Both a library of 
secreted random tridecapeptides and a mammalian/yeast hybrid Gα subunit were employed 
for histidine prototrophic selection via the FUS1 − HIS3 reporter gene. Subsequent peptidic 
candidate surrogate agonist screens have been successful.
In the case of olfactory receptors (ORs), Minic et al. optimized a yeast system for functional 
expression of rat I7 OR and subsequent characterization. In engineered yeasts lacking endog-
enous Gpa1p, the olfactory-specific Gα subunit (Gα
olf
) was co-expressed. When the receptor 
was activated by its ligands, MAPK signaling was switched on and luciferase (as a functional 
reporter) synthesis was induced [71]. Marrakchi et al. successfully expressed human olfactory 
receptor OR17-40 in yeast based on Minic’s biosensor system to detect the conductometric 
changes [94]. Fukutani et al. improved the firefly luciferase-based biomimetic odor-sensing 
system [60], and replaced the N-terminal region of mOR226 with the corresponding domain 
of the rat I7 receptor [95]. They further improved some ORs by the coexpression of either 
odorant accessory binding proteins or the receptor transporting protein 1 short (RTP1S) [96]. 
Tehseen et al. demonstrated that the Caenorhabditis elegans olfactory GPCR ODR-10 was func-
tionally expressed in yeast by using chimeric Gpa1/C. elegans Gα [97]. Mukherjee et al. con-
structed a medium-chain fatty acid biosensor by using the olfactory receptor OR1G1 that 
functionally expressed in yeast [98].
2.4. Yeast cell-surface display technology for single-cell signaling assay of GPCR 
peptides
Yeast cell-surface display technology is a platform to tether functional proteins and peptides 
expressed in yeast to the cell surface [99–102]. Cell-surface display of peptides can be used 
as a powerful ligand screening based on the yeast GPCR signaling assay systems [70, 103]. 
Displaying peptidic ligands by fusing them to an anchor protein in the yeast can enable a 
series of biological processes within a single cell, from peptide synthesis to agonist detection 
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against an already expressing cognate GPCR. In such a system, a library of peptides is indi-
vidually tethered to the plasma membrane on GPCR-producing yeast cells via attachment to 
a glycosyl-phosphatidylinositol (GPI) anchor. Upon phosphatidylinositol-specific phospho-
lipase C (PI-PLC) cleavage of the GPI, the peptides, which are fused to the anchor protein, 
are released from the membrane and trapped in the cell wall [103]. In principle, the host cells 
unconsciously detect the binding of peptidic ligands to relevant receptors on the membrane 
and report the peptides resulting agonistic activation. Thus, this technique facilitates concom-
itant library synthesis and identification of peptide ligands at the single-cell level [104, 105].
Ishii et al. have developed a system for cell wall trapping of autocrine peptides (CWTrAP), 
which activates human SSTR5 signaling using short anchor proteins (e.g., 42 a.a. of Flo1p; 
Flo42) [103]. The engineered yeast strain concomitantly expressing human SSTR5 and 
somatostatin peptide successfully induced GFP reporter gene expression. Hara et al. dem-
onstrated that the somatostatin displayed on the plasma membrane successfully activated 
human SSTR2 in yeast [106]. In this system, somatostatin was displayed on the yeast plasma 
membrane by linking it to the anchoring domain of the GPI-anchored plasma membrane 
protein Yps1p. Nakamura et al. drastically improved the sensitivity and output of this fluo-
rescence reporter system using the ZsGreen reporter, which is applicable to CWTrAP tech-
nology [70].
3. Oligomerization among GPCRs
Many GPCRs have the capacity to form homomers or heteromers that show unique functional 
and biochemical characteristics including receptor pharmacology, regulation, and signaling 
[14, 107, 108]. Therefore, GPCR oligomers could be potential molecular targets for the devel-
opment of new therapeutic agents. Yeast is a potential host for making cell-based biosensors 
for eukaryotic proteins and biological processes of interest [109], because varied reporting 
systems are available that can facilitate assays in yeast cells [110–112]. Notably, the “gold stan-
dard” for testing protein-protein interactions in vivo, Y2H systems, makes use of these report-
ers [113–115] and has also been used to identify membrane protein interaction partners [116].
3.1. Biophysical RET technologies to study GPCR oligomers in yeast cells
Varieties of resonance energy transfer (RET)-based techniques have promoted the visualiza-
tion of GPCR oligomers in living cells. Fluorescence resonance energy transfer (FRET) is a 
strictly distance-dependent energy transfer technique using a cyan fluorescent protein (CFP) 
as energy donor and a yellow fluorescent protein (YFP) as energy acceptor, but other pairings 
are also possible [117]. Highly sensitive, bioluminescence resonance energy transfer (BRET) is 
based on the distance-dependent transfer of energy between a bioluminescent energy donor 
and a fluorescent acceptor molecule [118, 119].
Overton and Blumer [120] used subcellular fractionation and CFP/YFP FRET to demonstrate 
that oligomerization of the endogenous mating pheromone Ste2p receptors occurs via a stable 
association between protomers in yeast. Subsequently, the authors employed FRET in live 
yeast cells for detection of Ste2p oligomerization with its transmembrane domains [121–124]. 
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Furthermore, FRET experiments with yeast cells demonstrated the oligomer formation of 
functional human complement factor 5a (C5a) receptors [125].
BRET was later used to increase the detection sensitivity for Ste2p oligomerization. Increased 
sensitivity was needed, because the C-terminal regions of full length Ste2p protomers did not 
reach a proximity sufficient for effective energy transfer [126]. With the BRET system, Gehret 
et al. [126] demonstrated that mutations previously reported as blocking Ste2p receptor oligo-
merization decreased but did not completely eliminate oligomerization. Previously, BRET 
has been employed in yeast to analyze the protein interactions involved with heterogeneous 
olfactory receptors [127, 128].
3.2. Membrane Y2H technology to study GPCR oligomers in yeast cells
In contrast to FRET and BRET technologies (see Section 3.1), mY2H method is based on tran-
scription-dependent reporter gene assays, permitting colorimetric evaluations with lacZ and 
growth selections with ADE2 and HIS3 (detected by complementation of auxotrophies) [129]. 
Therefore, the split-ubiquitin mY2H approach can be employed both for quantitative assays 
and for comprehensive screening of protein-protein interactions of membrane proteins [129].
In the split-ubiquitin mY2H system, the N- and C-terminal halves (NubG and Cub, respectively) 
of ubiquitin are fused to separate membrane proteins (Figure 2A and B). NubG represent a 
mutant version of the N-terminal half of ubiquitin that harbors an Ile-13 to Gly substitution. This 
split-ubiquitin system functions when interaction between the membrane proteins results in 
ubiquitin reassembly. Notably, Cub is fused to a membrane protein along with an artificial tran-
scription factor (LexA-VP16). NubG has a very low intrinsic affinity for Cub, and therefore can 
interact with Cub only if the membrane proteins fused to both ubiquitin fragments have affinities 
for each other [130]. The reconstituted ubiquitin is recognized by ubiquitin-specific proteases, 
and cleavage liberates LexA-VP16. The released transcription factor then enters the nucleus and 
induces the transcription of reporter genes, permitting both screening (via lacZ expression) and 
selection (via ADE2 and HIS3 expression) based on interactions between membrane proteins.
Historically, the split-ubiquitin mY2H system was employed to screen interacting membrane-
associated proteins (not GPCRs) for GPCRs, such as the μ-opioid receptor (MOR) [131, 132] 
and the M
3
 muscarinic acetylcholine receptor (M3R) [133]. Jin et al. identified GPR177, the 
mammalian ortholog of Drosophila melanogaster Wntless, as a novel MOR-interacting protein 
using the split-ubiquitin mY2H system [131]. Further work showed both enhanced MOR/
GPR177 complex formation at the cell periphery and inhibited Wnt secretion in response to 
morphine treatment, possibly causing decreased neurogenesis. Rosemond et al. investigated 
the predicted integral membrane protein Tmem147 and discovered that it functions as a novel 
M3R-associated protein [133]. Additional work also indicated that Tmem147 is as a potent 
M3R negative regulator, which may interfere with M3R trafficking to the cell surface.
The split-ubiquitin mY2H system has also been applied to identify GPCR heteromers [34]. 
Nakamura et al. developed a specialized method to screen candidate heteromer partners for 
target human GPCRs based on the split-ubiquitin mY2H method [34]. The authors noted 
that mating-associated induction of cell-cycle arrest, which causes robust growth inhibi-
tion in yeast, might impair the assessment of reporter gene activity. Therefore, the authors 
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Figure 2. Schematic illustration of the yeast split-ubiquitin mY2H system to study GPCR oligomers. (A and C) 
No-oligomerization pairs. (B and D) Oligomerization pairs. The candidate GPCR oligomer pairs are fused to respective 
split-ubiquitin segments (NubG and Cub), and Cub is further fused to an artificial transcription factor (LexA-VP16). 
NubG and Cub become close in proximity only when the GPCRs form a dimer, leading to the reconstitution of the split-
ubiquitin. Ubiquitin-specific proteases (UBPs) can recognize the reconstituted split-ubiquitin, resulting in LexA-VP16 
transcription factor cleavage from the Cub-fused GPCRs. LexA-VP16 diffuses into the nucleus where it binds to lexA-
binding sites on the lexA operator (lexAop). (A and B) Principal GPCR oligomer pair detection system: the reporter 
genes such as HIS3, ADE2, and lacZ are placed downstream of lexAop, and their expressions are induced when GPCR 
oligomer pairs interact with each other. (C and D) The reporter switching system for detecting GPCR oligomer pairs: the 
expressions of two reporter genes (E2Crimson and ZsGreen) are switched in response to the Y2H readout; one (E2Crimson) 
from ON to OFF and the other (ZsGreen) from OFF to ON. Briefly, after the release of the LexA-VP16 transcription factor, 
the lexA operator induces the expression of Cre recombinase, which causes a gene recombination that pops-out the 
E2Crimson gene and alternatively exposes the ZsGreen gene. Thus, the formation of GPCR oligomers can be discerned by 
monitoring the changes from far-red fluorescence to green fluorescence.
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constructed a MAPK signal-defective yeast strain. This modified host permitted the rapid 
and facile detection, not only of target human GPCR heteromerization, but also of ligand-
mediated conformational changes in living yeast cells [34]. Thus, the modified mY2H would 
be available to identify GPCR heteromer components and potential therapeutic targets for 
regulating physiological activities.
Furthermore, the authors subsequently designed a reporter switching system that can switch the 
expressions between two reporter genes (one from ON to OFF and the other from OFF to ON) in 
response to the Y2H readout (Figure 2C and D) [134]. Cre/loxP site-specific recombination was 
employed to induce reporter switching. The authors were able to utilize the split-ubiquitin mY2H 
system to optimize Cre-mediated reporter gene recombination and build a dual-color reporter 
switching system, which could discern GPCR dimer formation. To demonstrate reporter switch-
ing, the authors used a far-red derivative of the tetrameric fluorescent protein DsRed-Express2 
(E2Crimson) and a tetrameric ZsGreen as the two reporter genes. Reporter gene expression was 
successfully switched in the engineered yeast cells and permitted the detection of the dimerized 
yeast endogenous pheromone receptor (Ste2p). The authors also validated the applicability of 
this system for monitoring the formation of human GPCRs homodimers and heterodimers, spe-
cifically human serotonin 1A receptor or β2-adrenergic receptor, and confirmed that this system 
had improved sensitivity when compared with the previous system [134].
Using a modified split-ubiquitin mY2H approach, Sokolina et al. reported the systematic 
interactome analysis of 48 clinically important human GPCRs in their ligand-unoccupied 
state [135]. The authors also carried out additional in-depth functional validation on selected 
GPCR protein-protein interactions using biochemical and cell-based assays as well as knock-
out and knock-in animals. The authors found that a G-protein-regulated inducer of neurite 
outgrowth 2 (GPRIN2) and the GPR37 receptor, both physically and functionally, interact 
with the serotonin 5-HT4d receptor, a promising target for Alzheimer’s disease [135].
3.3. GPCR oligomerization and G-protein signaling
GPCR oligomerization can increase the potential for diversity in the regulation and modula-
tion of GPCR signaling, and thus the specific evaluation of signaling properties among various 
receptor oligomer pairs. This work has important implications, not only for the development of 
new drugs, but also for the understanding of signaling networks [22]. This unique system was 
developed for simultaneous detection of oligomer formation and GPCR signaling activation. 
This new methodology uses a combination of the split-ubiquitin mY2H assay and a G-protein 
signaling assay, and is expected to facilitate the identification of physiologically relevant GPCR 
oligomers [136]. Using this system, Nakamura et al. monitored the physiological relevance of 
yeast pheromone receptor Ste2p, in both native and mutated forms. In addition, the authors 
demonstrated the simultaneous detection of homo- and heteromerization, and somatostatin-
induced signaling of the human SSTR5 somatostatin receptor [136]. In the future, this system 
will be useful for identifying agonists that bind to the heteromer, promising to serve as a pow-
erful platform for uncovering the novel functions, modes of action, and potential molecular 
targets of GPCR heteromerization for the development of new therapeutic agents.
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4. Conclusion
In summary, we focused on yeast-based biosensors employed for the detection of GPCR 
ligand stimulation and oligomer formation, and described yeast-based techniques using the 
G-protein signaling and protein-protein interaction assays. Due to their involvement in signal 
transduction machinery, GPCRs are excellent therapeutic targets for various diseases and 
clinical indications [137]. The identification of new physiologically relevant GPCR oligomers 
provides a promising opportunity for drug discovery, based on the effect of allosteric com-
munication between GPCR protomers (each subunit within the oligomer complex) on known 
pharmacological properties. Thus, approaches for investigating the relationship between 
oligomerization and GPCR signaling are necessary for creating oligomer-specific bivalent 
ligands. Additionally, there is great potential for identifying previously undiscovered physio-
logical diversities and therapeutic targets through the generation of comprehensive and inter-
active GPCR oligomer maps. It is also important to expand our knowledge of the molecular 
details of GPCR-mediated signal transduction, including the identification of all proteins that 
interact with clinically relevant GPCRs. Further development of various methods, including 
yeast-based approaches and the investigation of GPCR oligomers, are expected to facilitate 
these outcomes in the near future.
Acknowledgements
This work was supported in part by a Grant-in-Aid for Young Scientists (B) from the Japan 
Society for the Promotion of Science (JSPS), and a Special Coordination Funds for Promoting 
Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary 
Research Areas (Innovative Bioproduction Kobe; iBioK) from the Ministry of Education, 
Culture, Sports, Science and Technology (MEXT) of Japan.
Conflict of interest
The authors declare no commercial or financial conflict of interest.
Author details
Yasuyuki Nakamura1, Akihiko Kondo1,2 and Jun Ishii1*
*Address all correspondence to: junjun@port.kobe-u.ac.jp
1 Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Japan
2 Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe 
University, Kobe, Japan
Peripheral Membrane Proteins36
References
[1] Wang Y, Dohlman HG. Regulation of G protein and mitogen-activated protein kinase 
signaling by ubiquitination: Insights from model organisms. Circulation Research. 
2006;99:1305-1314. DOI: 10.1161/01.RES.0000251641.57410.81
[2] Vögler O, Barceló JM, Ribas C, Escribá PV. Membrane interactions of G proteins and other 
related proteins. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2008;1778:1640-
1652. DOI: 10.1016/j.bbamem.2008.03.008
[3] Fredriksson R, Lagerström MC, Lundin LG, Schiöth HB. The G-protein-coupled recep-
tors in the human genome form five main families. Phylogenetic analysis, paralogon 
groups, and fingerprints. Molecular Pharmacology. 2003;63:1256-1272. DOI: 10.1124/
mol.63.6.1256
[4] Kim TH, Chung KY, Manglik A, Hansen AL, Dror RO, Mildorf TJ, Shaw DE, Kobilka BK, 
Prosser RS. The role of ligands on the equilibria between functional states of a G protein-
coupled receptor. Journal of the American Chemical Society. 2013;135:9465-9474. DOI: 
10.1021/ja404305k
[5] Nieto Gutierrez A, McDonald PH. GPCRs: Emerging anti-cancer drug targets. Cellular 
Signalling. 2018;41:65-74. DOI: 10.1016/j.cellsig.2017.09.005
[6] Venkatakrishnan AJ, Deupi X, Lebon G, Tate CG, Schertler GF, Babu MM. Molecular 
signatures of G-protein-coupled receptors. Nature. 2013;494:185-194. DOI: 10.1038/
nature11896
[7] Katritch V, Cherezov V, Stevens RC. Diversity and modularity of G protein-coupled recep-
tor structures. Trends in Pharmacological Sciences. 2012;33:17-27. DOI: 10.1016/j.tips. 
2011.09.003
[8] Wise A, Gearing K, Rees S. Target validation of G-protein coupled receptors. Drug 
Discovery Today. 2002;7:235-246. DOI: 10.1016/S1359-6446(01)02131-6
[9] Ghosh E, Kumari P, Jaiman D, Shukla AK. Methodological advances: The unsung heroes 
of the GPCR structural revolution. Nature Reviews Molecular Cell Biology. 2015;16:69-
81. DOI: 10.1038/nrm3933
[10] Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-
coupled receptors. Nature. 2009;459:356-363. DOI: 10.1038/nature08144
[11] Karnik SS, Gogonea C, Patil S, Saad Y, Takezako T. Activation of G-protein-coupled 
receptors: A common molecular mechanism. Trends in Endocrinology & Metabolism. 
2003;14:431-437. DOI: 10.1016/j.tem.2003.09.007
[12] Park PS, Filipek S, Wells JW, Palczewski K. Oligomerization of G protein-coupled 
receptors: Past, present, and future. Biochemistry. 2004;43:15643-15656. DOI: 10.1021/
bi047907k
[13] Devi LA. G-protein-coupled receptor dimers in the lime light. Trends in Pharmacological 
Sciences. 2000;21:324-326. DOI: 10.1016/S0165-6147(00)01519-4
Biosensing Techniques in Yeast: G-Protein Signaling and Protein-Protein Interaction Assays…
http://dx.doi.org/10.5772/intechopen.76330
37
[14] Ferré S, Casadó V, Devi LA, Filizola M, Jockers R, Lohse MJ, Milligan G, Pin JP, Guitart 
X. G protein-coupled receptor oligomerization revisited: Functional and pharmacologi-
cal perspectives. Pharmacological Reviews. 2014;66:413-434. DOI: 10.1124/pr.113.008052
[15] Milligan G. G protein-coupled receptor dimerization: Function and ligand pharmacol-
ogy. Molecular Pharmacology. 2004;66:1-7. DOI: 10.1124/mol.104.000497
[16] White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, 
Foord SM, Marshall FH. Heterodimerization is required for the formation of a functional 
GABA(B) receptor. Nature. 1998;396:679-682. DOI: 10.1038/25354
[17] Smith NJ, Milligan G. Allostery at G protein-coupled receptor homo- and heteromers: 
Uncharted pharmacological landscapes. Pharmacological Reviews. 2010;62:701-725. 
DOI: 10.1124/pr.110.002667
[18] Xue L, Rovira X, Scholler P, Zhao H, Liu J, Pin JP, Rondard P. Major ligand-induced 
rearrangement of the heptahelical domain interface in a GPCR dimer. Nature Chemical 
Biology. 2015;11:134-140. DOI: 10.1038/nchembio.1711
[19] Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nature Reviews 
Neuroscience. 2001;2:274-286. DOI: 10.1038/35067575
[20] Bulenger S, Marullo S, Bouvier M. Emerging role of homo- and heterodimerization in 
G-protein-coupled receptor biosynthesis and maturation. Trends in Pharmacological 
Sciences. 2005;26:131-137. DOI: 10.1016/j.tips.2005.01.004
[21] Devi LA. Heterodimerization of G-protein-coupled receptors: Pharmacology, signal-
ing and trafficking. Trends in Pharmacological Sciences. 2001;22:532-537. DOI: 10.1016/
S0165-6147(00)01799-5
[22] Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates recep-
tor function. Nature. 1999;399:697-700. DOI: 10.1038/21441
[23] Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA. Oligomerization of opioid recep-
tors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein 
kinase activation. Proceedings of the National Academy of Sciences of the United States 
of America. 2001;98:343-348. DOI: 10.1073/pnas.011384898
[24] Terrillon S, Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO 
Reports. 2004;5:30-34. DOI: 10.1038/sj.embor.7400052
[25] Lane JR, Donthamsetti P, Shonberg J, Draper-Joyce CJ, Dentry S, Michino M, Shi L, 
López L, Scammells PJ, Capuano B, Sexton PM, Javitch JA, Christopoulos A. A new 
mechanism of allostery in a G protein-coupled receptor dimer. Nature Chemical Biology. 
2014;10:745-752. DOI: 10.1038/nchembio.1593
[26] Teitler M, Klein MT. A new approach for studying GPCR dimers: Drug-induced 
inactivation and reactivation to reveal GPCR dimer function in vitro, in primary cul-
ture, and in vivo. Pharmacology & Therapeutics. 2012;133:205-217. DOI: 10.1016/j.
pharmthera.2011.10.007
[27] George SR, O’Dowd BF, Lee SP. G-protein-coupled receptor oligomerization and its 
potential for drug discovery. Nature Reviews Drug Discovery. 2002;1:808-820. DOI: 
10.1038/nrd913
Peripheral Membrane Proteins38
[28] Hiller C, Kühhorn J, Gmeiner P. Class A G-protein-coupled receptor (GPCR) dimers 
and bivalent ligands. Journal of Medicinal Chemistry. 2013;56:6542-6559. DOI: 10.1021/
jm4004335
[29] Le Naour M, Lunzer MM, Powers MD, Kalyuzhny AE, Benneyworth MA, Thomas MJ, 
Portoghese PS. Putative kappa opioid heteromers as targets for developing analgesics 
free of adverse effects. Journal of Medicinal Chemistry. 2014;57:6383-6392. DOI: 10.1021/
jm500159d
[30] Ishii J, Fukuda N, Tanaka T, Ogino C, Kondo A. Protein-protein interactions and selec-
tion: Yeast-based approaches that exploit guanine nucleotide-binding protein signaling. 
FEBS Journal. 2010;277:1982-1995. DOI: 10.1111/j.1742-4658.2010.07625.x
[31] Minic J, Sautel M, Salesse R, Pajot-Augy E. Yeast system as a screening tool for phar-
macological assessment of G protein coupled receptors. Current Medicinal Chemistry. 
2005;12:961-969. DOI: 10.2174/0929867053507261
[32] Brown AJ, Dyos SL, Whiteway MS, White JH, Watson MA, Marzioch M, Clare JJ, 
Cousens DJ, Paddon C, Plumpton C, Romanos MA, Dowell SJ. Functional cou-
pling of mammalian receptors to the yeast mating pathway using novel yeast/
mammalian G protein α-subunit chimeras. Yeast. 2000;16:11-22. DOI: 10.1002/
(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K
[33] Stagljar I, Korostensky C, Johnsson N, te Heesen S. A genetic system based on split-ubiq-
uitin for the analysis of interactions between membrane proteins in vivo. Proceedings 
of the National Academy of Sciences of the United States of America. 1998;95:5187-5192
[34] Nakamura Y, Ishii J, Kondo A. Rapid, facile detection of heterodimer partners for target 
human G-protein-coupled receptors using a modified split-ubiquitin membrane yeast 
two-hybrid system. PLoS One. 2013;8:e66793. DOI: 10.1371/journal.pone.0066793
[35] Cotton M, Claing A. G protein-coupled receptors stimulation and the control of cell 
migration. Cellular Signalling. 2009;21:1045-1053. DOI: 10.1016/j.cellsig.2009.02.008
[36] Dupré DJ, Robitaille M, Rebois RV, Hébert TE. The role of Gbetagamma subunits in 
the organization, assembly, and function of GPCR signaling complexes. Annual Review 
of Pharmacology and Toxicology. 2009;49:31-56. DOI: 10.1146/annurev-pharmtox- 
061008-103038
[37] Ritter SL, Hall RA. Fine-tuning of GPCR activity by receptor-interacting proteins. Nature 
Reviews Molecular Cell Biology. 2009;10:819-830. DOI: 10.1038/nrm2803
[38] Bardwell L. A walk-through of the yeast mating pheromone response pathway. Peptides. 
2005;26:339-350. DOI: 10.1016/j.peptides.2003.10.022
[39] Elion EA. Pheromone response, mating and cell biology. Current Opinion in Micro-
biology. 2000;3:573-581. DOI: 10.1016/S1369-5274(00)00143-0
[40] Alvaro CG, Thorner J. Heterotrimeric G protein-coupled receptor signaling in yeast 
mating pheromone response. Journal of Biological Chemistry. 2016;291:7788-7795. DOI: 
10.1074/jbc.R116.714980
[41] Leberer E, Thomas DY, Whiteway M. Pheromone signalling and polarized morphogen-
esis in yeast. Current Opinion in Genetics & Development. 1997;7:59-66. DOI: 10.1016/
S0959-437X(97)80110-4
Biosensing Techniques in Yeast: G-Protein Signaling and Protein-Protein Interaction Assays…
http://dx.doi.org/10.5772/intechopen.76330
39
[42] Leeuw T, Wu C, Schrag JD, Whiteway M, Thomas DY, Leberer E. Interaction of a 
G-protein beta-subunit with a conserved sequence in Ste20/PAK family protein kinases. 
Nature. 1998;391:191-195. DOI: 10.1038/34448
[43] Elion EA. The Ste5p scaffold. Journal of Cell Science. 2001;114:3967-3978
[44] Pryciak PM, Huntress FA. Membrane recruitment of the kinase cascade scaffold protein 
Ste5 by the Gβγ complex underlies activation of the yeast pheromone response pathway. 
Genes & Development. 1998;12:2684-2697. DOI: 10.1101/gad.12.17.2684
[45] Chang F, Herskowitz I. Identification of a gene necessary for cell cycle arrest by a nega-
tive growth factor of yeast: FAR1 is an inhibitor of a G1 cyclin, CLN2. Cell. 1990;63:999-
1011. DOI: 10.1016/0092-8674(90)90503-7
[46] Chang F, Herskowitz I. Phosphorylation of FAR1 in response to alpha-factor: A possible 
requirement for cell-cycle arrest. Molecular Biology of the Cell. 1992;3:445-450. DOI: 
10.1091/mbc.3.4.445
[47] McKinney JD, Cross FR. FAR1 and the G1 phase specificity of cell cycle arrest by mating 
factor in Saccharomyces cerevisiae. Molecular and Cellular Biology. 1995;15:2509-2516. 
DOI: 10.1128/MCB.15.5.2509
[48] Dolan JW, Kirkman C, Fields S. The yeast STE12 protein binds to the DNA sequence 
mediating pheromone induction. Proceedings of the National Academy of Sciences of 
the United States of America. 1989;86:5703-5707
[49] Song D, Dolan JW, Yuan YL, Fields S. Pheromone-dependent phosphorylation of the 
yeast STE12 protein correlates with transcriptional activation. Genes & Development. 
1991;5:741-750. DOI: 10.1101/gad.5.5.741
[50] McCaffrey G, Clay FJ, Kelsay K, Sprague GF Jr. Identification and regulation of a gene 
required for cell fusion during mating of the yeast Saccharomyces cerevisiae. Molecular 
and Cellular Biology. 1987;7:2680-2690. DOI: 10.1128/MCB.7.8.2680
[51] Hagen DC, McCaffrey G, Sprague GF Jr. Pheromone response elements are neces-
sary and sufficient for basal and pheromone-induced transcription of the FUS1 gene 
of Saccharomyces cerevisiae. Molecular and Cellular Biology. 1991;11:2952-2961. DOI: 
10.1128/MCB.11.6.2952
[52] Zeitlinger J, Simon I, Harbison CT, Hannett NM, Volkert TL, Fink GR, Young RA. Program-
specific distribution of a transcription factor dependent on partner transcription factor 
and MAPK signaling. Cell. 2003;113:395-404. DOI: 10.1016/S0092-8674(03)00301-5
[53] White JM, Rose MD. Yeast mating: Getting close to membrane merger. Current Biology. 
2001;11:R16-R20. DOI: 10.1016/S0960-9822(00)00036-1
[54] Chasse SA, Flanary P, Parnell SC, Hao N, Cha JY, Siderovski DP, Dohlman HG. Genome-
scale analysis reveals Sst2 as the principal regulator of mating pheromone signaling 
in the yeast Saccharomyces cerevisiae. Eukaryotic Cell. 2006;5:330-346. DOI: 10.1128/
EC.5.2.330-346.2006
Peripheral Membrane Proteins40
[55] Dohlman HG, Song J, Ma D, Courchesne WE, Thorner J. Sst2, a negative regulator of 
pheromone signaling in the yeast Saccharomyces cerevisiae: Expression, localization, 
and genetic interaction and physical association with Gpa1 (the G-protein alpha sub-
unit). Molecular and Cellular Biology. 1996;16:5194-5209. DOI: 10.1128/MCB.16.9.5194
[56] Apanovitch DM, Slep KC, Sigler PB, Dohlman HG. Sst2 is a GTPase-activating protein 
for Gpa1: Purification and characterization of a cognate RGS-Gα protein pair in yeast. 
Biochemistry. 1998;37:4815-4822. DOI: 10.1021/bi9729965
[57] Dohlman HG, Apaniesk D, Chen Y, Song J, Nusskern D. Inhibition of G-protein sig-
naling by dominant gain-of-function mutations in Sst2p, a pheromone desensitization 
factor in Saccharomyces cerevisiae. Molecular and Cellular Biology. 1995;15:3635-3643. 
DOI: 10.1128/MCB.15.7.3635
[58] Ishii J, Matsumura S, Kimura S, Tatematsu K, Kuroda S, Fukuda H, Kondo A. Quantitative 
and dynamic analyses of G protein-coupled receptor signaling in yeast using Fus1, 
enhanced green fluorescence protein (EGFP), and His3 fusion protein. Biotechnology 
Progress. 2006;22:954-960. DOI: 10.1021/bp0601387
[59] Evans BJ, Wang Z, Broach JR, Oishi S, Fujii N, Peiper SC. Expression of CXCR4, a G-protein-
coupled receptor for CXCL12 in yeast. Identification of new-generation inverse agonists. 
Methods in Enzymology. 2009;460:399-412. DOI: 10.1016/S0076-6879(09)05220-3
[60] Fukutani Y, Ishii J, Noguchi K, Kondo A, Yohda M. An improved bioluminescence-based 
signaling assay for odor sensing with a yeast expressing a chimeric olfactory receptor. 
Biotechnology and Bioengineering. 2012;109:3143-3151. DOI: 10.1002/bit.24589
[61] Pausch MH. G-protein-coupled receptors in Saccharomyces cerevisiae: High-throughput 
screening assays for drug discovery. Trends in Biotechnology. 1997;15:487-494. DOI: 
10.1016/S0167-7799(97)01119-0
[62] Ishii J, Tanaka T, Matsumura S, Tatematsu K, Kuroda S, Ogino C, Fukuda H, Kondo 
A. Yeast-based fluorescence reporter assay of G protein-coupled receptor signalling for 
flow cytometric screening: FAR1-disruption recovers loss of episomal plasmid caused 
by signalling in yeast. The Journal of Biochemistry. 2008;143:667-674. DOI: 10.1093/jb/
mvn018
[63] Ladds G, Goddard A, Davey J. Functional analysis of heterologous GPCR signal-
ling pathways in yeast. Trends in Biotechnology. 2005;23:367-373. DOI: 10.1016/j.
tibtech.2005.05.007
[64] Leplatois P, Josse A, Guillemot M, Febvre M, Vita N, Ferrara P, Loison G. Neurotensin 
induces mating in Saccharomyces cerevisiae cells that express human neurotensin 
receptor type 1 in place of the endogenous pheromone receptor. European Journal of 
Biochemistry. 2001;268:4860-4867. DOI: 10.1046/j.0014-2956.2001.02407.x
[65] Price LA, Kajkowski EM, Hadcock JR, Ozenberger BA, Pausch MH. Functional cou-
pling of a mammalian somatostatin receptor to the yeast pheromone response pathway. 
Molecular and Cellular Biology. 1995;15:6188-6195. DOI: 10.1128/MCB.15.11.6188
Biosensing Techniques in Yeast: G-Protein Signaling and Protein-Protein Interaction Assays…
http://dx.doi.org/10.5772/intechopen.76330
41
[66] Erlenbach I, Kostenis E, Schmidt C, Hamdan FF, Pausch MH, Wess J. Functional 
expression of M1, M3 and M5 muscarinic acetylcholine receptors in yeast. Journal of 
Neurochemistry. 2001;77:1327-1337. DOI: 10.1046/j.1471-4159.2001.00344.x
[67] Li B, Scarselli M, Knudsen CD, Kim SK, Jacobson KA, McMillin SM, Wess J. Rapid iden-
tification of functionally critical amino acids in a G protein-coupled receptor. Nature 
Methods. 2007;4:169-174. DOI: 10.1038/nmeth990
[68] Pausch MH, Lai M, Tseng E, Paulsen J, Bates B, Kwak S. Functional expression of human 
and mouse P2Y12 receptors in Saccharomyces cerevisiae. Biochemical and Biophysical 
Research Communications. 2004;324:171-177. DOI: 10.1016/j.bbrc.2004.09.034
[69] Kaishima M, Ishii J, Matsuno T, Fukuda N, Kondo A. Expression of varied GFPs in 
Saccharomyces cerevisiae: Codon optimization yields stronger than expected expres-
sion and fluorescence intensity. Scientific Reports. 2016;6:35932. DOI: 10.1038/srep35932
[70] Nakamura Y, Ishii J, Kondo A. Bright fluorescence monitoring system utilizing Zoanthus 
sp. green fluorescent protein (ZsGreen) for human G-protein-coupled receptor signal-
ing in microbial yeast cells. PLoS One. 2013;8:e82237. DOI: 10.1371/journal.pone.0082237
[71] Minic J, Persuy MA, Godel E, Aioun J, Connerton I, Salesse R, Pajot-Augy E. Functional 
expression of olfactory receptors in yeast and development of a bioassay for odorant 
screening. The FEBS Journal. 2005;272:524-537. DOI: 10.1111/j.1742-4658.2004.04494.x
[72] King K, Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. Control of yeast mating 
signal transduction by a mammalian beta 2-adrenergic receptor and Gs alpha subunit. 
Science. 1990;250:121-123. DOI: 10.1126/science.2171146
[73] Liu R, Wong W, IJzerman AP. Human G protein-coupled receptor studies in Saccharomyces 
cerevisiae. Biochemical Pharmacology. 2016;114:103-115. DOI: 10.1016/j.bcp.2016.02.010
[74] Raynor K, Murphy WA, Coy DH, Taylor JE, Moreau JP, Yasuda K, Bell GI, Reisine T. 
Cloned somatostatin receptors: Identification of subtype-selective peptides and dem-
onstration of high affinity binding of linear peptides. Molecular Pharmacology. 1993; 
43:838-844
[75] Raynor K, O’Carroll AM, Kong H, Yasuda K, Mahan LC, Bell GI, Reisine T. Characterization 
of cloned somatostatin receptors SSTR4 and SSTR5. Molecular Pharmacology. 1993;44: 
385-392
[76] Jaquet P, Saveanu A, Gunz G, Fina F, Zamora AJ, Grino M, Culler MD, Moreau JP, 
Enjalbert A, Ouafik LH. Human somatostatin receptor subtypes in acromegaly: Distinct 
patterns of messenger ribonucleic acid expression and hormone suppression identify 
different tumoral phenotypes. The Journal of Clinical Endocrinology & Metabolism. 
2000;85:781-792. DOI: 10.1210/jcem.85.2.6338
[77] Iguchi Y, Ishii J, Nakayama H, Ishikura A, Izawa K, Tanaka T, Ogino C, Kondo A. Control 
of signalling properties of human somatostatin receptor subtype-5 by additional signal 
sequences on its amino-terminus in yeast. The Journal of Biochemistry. 2010;147:875-
884. DOI: 10.1093/jb/mvq023
Peripheral Membrane Proteins42
[78] Togawa S, Ishii J, Ishikura A, Tanaka T, Ogino C, Kondo A. Importance of asparagine 
residues at positions 13 and 26 on the amino-terminal domain of human somatostatin 
receptor subtype-5 in signalling. The Journal of Biochemistry. 2010;147:867-873. DOI: 
10.1093/jb/mvq022
[79] Fukuda N, Ishii J, Kaishima M, Kondo A. Amplification of agonist stimulation of human 
G-protein-coupled receptor signaling in yeast. Analytical Biochemistry. 2011;417:182-187. 
DOI: 10.1016/j.ab.2011.06.006
[80] White JF, Noinaj N, Shibata Y, Love J, Kloss B, Xu F, Gvozdenovic-Jeremic J, Shah P, 
Shiloach J, Tate CG, Grisshammer R. Structure of the agonist-bound neurotensin recep-
tor. Nature. 2012;490:508-513. DOI: 10.1038/nature11558
[81] Dupouy S, Mourra N, Doan VK, Gompel A, Alifano M, Forgez P. The potential use of 
the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a 
component of personalized medicine in selective cancers. Biochimie. 2011;93:1369-1378. 
DOI: 10.1016/j.biochi.2011.04.024
[82] Ishii J, Oda A, Togawa S, Fukao A, Fujiwara T, Ogino C, Kondo A. Microbial fluores-
cence sensing for human neurotensin receptor type 1 using Gα-engineered yeast cells. 
Analytical Biochemistry. 2014;446:37-43. DOI: 10.1016/j.ab.2013.10.016
[83] Hashi H, Nakamura Y, Ishii J, Kondo A. Modifying expression modes of human neuro-
tensin receptor type 1 alters sensing capabilities for agonists in yeast signaling biosensor. 
Biotechnology Journal. 2018;13:e1700522. DOI: 10.1002/biot.201700522
[84] Griendling KK, Lassègue B, Alexander RW. Angiotensin receptors and their therapeutic 
implications. Annual Review of Pharmacology and Toxicology. 1996;36:281-306. DOI: 
10.1146/annurev.pa.36.040196.001433
[85] Mehta PK, Griendling KK. Angiotensin II cell signaling: Physiological and pathological 
effects in the cardiovascular system. American Journal of Physiology Cell Physiology. 
2007;292:C82-C97. DOI: 10.1152/ajpcell.00287.2006
[86] Groblewski T, Maigret B, Larguier R, Lombard C, Bonnafous JC, Marie J. Mutation 
of Asn111 in the third transmembrane domain of the AT(1A) angiotensin II receptor 
induces its constitutive activation. Journal of Biological Chemistry. 1997;272:1822-1826. 
DOI: 10.1074/jbc.272.3.1822
[87] Balmforth AJ, Lee AJ, Warburton P, Donnelly D, Ball SG. The conformational change 
responsible for AT1receptor activation is dependent upon two juxtaposed aspara-
gine residues on transmembrane helices III and VII. Journal of Biological Chemistry. 
1997;272:4245-4251. DOI: 10.1074/jbc.272.7.4245
[88] Nakamura Y, Ishii J, Kondo A. Construction of a yeast-based signaling biosensor for 
human angiotensin II type 1 receptor via functional coupling between Asn295-mutated 
receptor and Gpa1/Gi3 chimeric Gα. Biotechnology and Bioengineering. 2014;111:2220-
2228. DOI: 10.1002/bit.25278
[89] Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, 
Humphrey PP. International Union of Pharmacology Classification of receptors for 
5-hydroxytryptamine (serotonin). Pharmacological Reviews. 1994;46:157-203
Biosensing Techniques in Yeast: G-Protein Signaling and Protein-Protein Interaction Assays…
http://dx.doi.org/10.5772/intechopen.76330
43
[90] Nakamura Y, Ishii J, Kondo A. Applications of yeast-based signaling sensor for charac-
terization of antagonist and analysis of site-directed mutants of the human serotonin 1A 
receptor. Biotechnology and Bioengineering. 2015;112:1906-1915. DOI: 10.1002/bit.25597
[91] Stewart GD, Sexton PM, Christopoulos A. Detection of novel functional selectivity at 
M3 muscarinic acetylcholine receptors using a Saccharomyces cerevisiae platform. ACS 
Chemical Biology. 2010;5:365-375. DOI: 10.1021/cb900276p
[92] Stewart GD, Sexton PM, Christopoulos A. Prediction of functionally selective allosteric 
interactions at an M3 muscarinic acetylcholine receptor mutant using Saccharomyces 
cerevisiae. Molecular Pharmacology. 2010;78:205-214. DOI: 10.1124/mol.110.064253
[93] Klein C, Paul JI, Sauvé K, Schmidt MM, Arcangeli L, Ransom J, Trueheart J, Manfredi 
JP, Broach JR, Murphy AJ. Identification of surrogate agonists for the human FPRL-1 
receptor by autocrine selection in yeast. Nature Biotechnology. 1998;16:1334-1337. DOI: 
10.1038/4310
[94] Marrakchi M, Vidic J, Jaffrezic-Renault N, Martelet C, Pajot-Augy E. A new concept of 
olfactory biosensor based on interdigitated microelectrodes and immobilized yeasts 
expressing the human receptor OR17-40. European Biophysics Journal. 2007;36:1015-
1018. DOI: 10.1007/s00249-007-0187-6
[95] Fukutani Y, Nakamura T, Yorozu M, Ishii J, Kondo A, Yohda M. The N-terminal replace-
ment of an olfactory receptor for the development of a yeast-based biomimetic odor 
sensor. Biotechnology and Bioengineering. 2012;109:205-212. DOI: 10.1002/bit.23327
[96] Fukutani Y, Hori A, Tsukada S, Sato R, Ishii J, Kondo A, Matsunami H, Yohda M. 
Improving the odorant sensitivity of olfactory receptor-expressing yeast with accessory 
proteins. Analytical Biochemistry. 2015;471:1-8. DOI: 10.1016/j.ab.2014.10.012
[97] Tehseen M, Dumancic M, Briggs L, Wang J, Berna A, Anderson A, Trowell S. Functional 
coupling of a nematode chemoreceptor to the yeast pheromone response pathway. 
PLoS One. 2014;9:e111429. DOI: 10.1371/journal.pone.0111429
[98] Mukherjee K, Bhattacharyya S, Peralta-Yahya P. GPCR-based chemical biosensors for 
medium-chain fatty acids. ACS Synthetic Biology. 2015;4:1261-1269. DOI: 10.1021/
sb500365m
[99] Ueda M, Tanaka A. Genetic immobilization of proteins on the yeast cell surface. 
Biotechnology Advances. 2000;18:121-140. DOI: 10.1016/S0734-9750(00)00031-8
[100] Kondo A, Ueda M. Yeast cell-surface display—Applications of molecular display. 
Applied Microbiology and Biotechnology. 2004;64:28-40. DOI: 10.1007/s00253-003-1492-3
[101] Gai SA, Wittrup KD. Yeast surface display for protein engineering and characterization. 
Current Opinion in Structural Biology. 2007;17:467-473. DOI: 10.1016/j.sbi.2007.08.012
[102] Pepper LR, Cho YK, Boder ET, Shusta EV. A decade of yeast surface display technol-
ogy: Where are we now? Combinatorial Chemistry & High Throughput Screening. 
2008;11:127-134. DOI: 10.2174/138620708783744516
Peripheral Membrane Proteins44
[103] Ishii J, Yoshimoto N, Tatematsu K, Kuroda S, Ogino C, Fukuda H, Kondo A. Cell wall 
trapping of autocrine peptides for human G-protein-coupled receptors on the yeast cell 
surface. PLoS One. 2012;7:e37136. DOI: 10.1371/journal.pone.0037136
[104] Müller S, Nebe-von-Caron G. Functional single-cell analyses: Flow cytometry and 
cell sorting of microbial populations and communities. FEMS Microbiology Reviews. 
2010;34:554-587. DOI: 10.1111/j.1574-6976.2010.00214.x
[105] Yoshimoto N, Tatematsu K, Iijima M, Niimi T, Maturana AD, Fujii I, Kondo A, Tanizawa 
K, Kuroda S. High-throughput de novo screening of receptor agonists with an auto-
mated single-cell analysis and isolation system. Scientific Reports. 2014;4:4242. DOI: 
10.1038/srep04242
[106] Hara K, Shigemori T, Kuroda K, Ueda M. Membrane-displayed somatostatin activates 
somatostatin receptor subtype-2 heterologously produced in Saccharomyces cerevi-
siae. AMB Express. 2012;2:63. DOI: 10.1186/2191-0855-2-63
[107] Ferré S. The GPCR heterotetramer: Challenging classical pharmacology. Trends in 
Pharmacological Sciences. 2015;36:145-152. DOI: 10.1016/j.tips.2015.01.002
[108] Milligan G. The prevalence, maintenance, and relevance of G protein-coupled recep-
tor oligomerization. Molecular Pharmacology. 2013;84:158-169. DOI: 10.1124/mol. 
113.084780
[109] Adeniran A, Sherer M, Tyo KE. Yeast-based biosensors: Design and applications. FEMS 
Yeast Research. 2015;15:1-15. DOI: 10.1111/1567-1364.12203
[110] Leskinen P, Virta M, Karp M. One-step measurement of firefly luciferase activity in 
yeast. Yeast. 2003;20:1109-1113. DOI: 10.1002/yea.1024
[111] Naylor LH. Reporter gene technology: The future looks bright. Biochemical 
Pharmacology. 1999;58:749-757. DOI: 10.1016/S0006-2952(99)00096-9
[112] Radhika V, Proikas-Cezanne T, Jayaraman M, Onesime D, Ha JH, Dhanasekaran 
DN. Chemical sensing of DNT by engineered olfactory yeast strain. Nature Chemical 
Biology. 2007;3:325-330. DOI: 10.1038/nchembio882
[113] Chen J, Zhou J, Bae W, Sanders CK, Nolan JP, Cai H. A yEGFP-based reporter sys-
tem for high-throughput yeast two-hybrid assay by flow cytometry. Cytometry Part A. 
2008;73:312-320. DOI: 10.1002/cyto.a.20525
[114] Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y. A comprehensive two-
hybrid analysis to explore the yeast protein interactome. Proceedings of the National 
Academy of Sciences of the United States of America. 2001;98:4569-4574. DOI: 10.1073/
pnas.061034498
[115] Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan 
V, Srinivasan M, Pochart P, Qureshi-Emili A, Li Y, Godwin B, Conover D, Kalbfleisch 
T, Vijayadamodar G, Yang M, Johnston M, Fields S, Rothberg JM. A comprehensive 
Biosensing Techniques in Yeast: G-Protein Signaling and Protein-Protein Interaction Assays…
http://dx.doi.org/10.5772/intechopen.76330
45
analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature. 
2000;403:623-627. DOI: 10.1038/35001009
[116] Babu M, Vlasblom J, Pu S, Guo X, Graham C, Bean BD, Burston HE, Vizeacoumar 
FJ, Snider J, Phanse S, Fong V, Tam YY, Davey M, Hnatshak O, Bajaj N, Chandran S, 
Punna T, Christopolous C, Wong V, Yu A, Zhong G, Li J, Stagljar I, Conibear E, Wodak 
SJ, Emili A, Greenblatt JF. Interaction landscape of membrane-protein complexes in 
Saccharomyces cerevisiae. Nature. 2012;489:585-589. DOI: 10.1038/nature11354
[117] Milligan G, Bouvier M. Methods to monitor the quaternary structure of G protein-coupled 
receptors. The FEBS Journal. 2005;272:2914-2925. DOI: 10.1111/j.1742-4658.2005.04731.x
[118] Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M. Detection 
of beta 2-adrenergic receptor dimerization in living cells using bioluminescence reso-
nance energy transfer (BRET). Proceedings of the National Academy of Sciences of the 
United States of America. 2000;97:3684-3689. DOI: 10.1073/pnas.060590697
[119] Issafras H, Angers S, Bulenger S, Blanpain C, Parmentier M, Labbé-Jullié C, Bouvier 
M, Marullo S. Constitutive agonist-independent CCR5 oligomerization and antibody-
mediated clustering occurring at physiological levels of receptors. Journal of Biological 
Chemistry. 2002;277:34666-34673. DOI: 10.1074/jbc.M202386200
[120] Overton MC, Blumer KJ. G-protein-coupled receptors function as oligomers in vivo. 
Current Biology. 2000;10:341-344. DOI: 10.1016/S0960-9822(00)00386-9
[121] Overton MC, Blumer KJ. Use of fluorescence resonance energy transfer to analyze oligo-
merization of G-protein-coupled receptors expressed in yeast. Methods. 2002;27:324-
332. DOI: 10.1016/S1046-2023(02)00090-7
[122] Overton MC, Blumer KJ. The extracellular N-terminal domain and transmembrane 
domains 1 and 2 mediate oligomerization of a yeast G protein-coupled receptor. Journal 
of Biological Chemistry. 2002;277:41463-41472. DOI: 10.1074/jbc.M205368200
[123] Overton MC, Chinault SL, Blumer KJ. Oligomerization, biogenesis, and signaling is 
promoted by a glycophorin A-like dimerization motif in transmembrane domain 1 of 
a yeast G protein-coupled receptor. Journal of Biological Chemistry. 2003;278:49369-
49377. DOI: 10.1074/jbc.M308654200
[124] Overton MC, Chinault SL, Blumer KJ. Oligomerization of G-protein-coupled receptors: 
Lessons from the yeast Saccharomyces cerevisiae. Eukaryotic Cell. 2005;4:1963-1970. 
DOI: 10.1128/EC.4.12.1963-1970.2005
[125] Floyd DH, Geva A, Bruinsma SP, Overton MC, Blumer KJ, Baranski TJ. C5a recep-
tor oligomerization. II. Fluorescence resonance energy transfer studies of a human 
G protein-coupled receptor expressed in yeast. Journal of Biological Chemistry. 
2003;278:35354-35361. DOI: 10.1074/jbc.M305607200
[126] Gehret AU, Bajaj A, Naider F, Dumont ME. Oligomerization of the yeast α-factor recep-
tor: Implications for dominant negative effects of mutant receptors. Journal of Biological 
Chemistry. 2006;281:20698-20714. DOI: 10.1074/jbc.M513642200
Peripheral Membrane Proteins46
[127] Tehseen M, Liao C, Dacres H, Dumancic M, Trowell S, Anderson A. Oligomerisation of 
C. Elegans olfactory receptors, ODR-10 and STR-112, in yeast. PLoS One. 2014;9:e108680. 
DOI: 10.1371/journal.pone.0108680
[128] Wade F, Espagne A, Persuy MA, Vidic J, Monnerie R, Merola F, Pajot-Augy E, Sanz 
G. Relationship between homo-oligomerization of a mammalian olfactory receptor 
and its activation state demonstrated by bioluminescence resonance energy transfer. 
Journal of Biological Chemistry. 2011;286:15252-15259. DOI: 10.1074/jbc.M110.184580
[129] Nakamura Y, Ishii J, Kondo A. Current techniques for studying oligomer formations 
of G-protein-coupled receptors using mammalian and yeast cells. Current Medicinal 
Chemistry. 2016;23:1638-1656. DOI: 10.2174/0929867323666160407113353
[130] Johnsson N, Varshavsky A. Split ubiquitin as a sensor of protein interactions in vivo. 
Proceedings of the National Academy of Sciences of the United States of America. 
1994;91:10340-10344
[131] Jin J, Kittanakom S, Wong V, Reyes BA, Van Bockstaele EJ, Stagljar I, Berrettini W, 
Levenson R. Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt 
secretion: Potential implications for opioid dependence. BMC Neuroscience. 2010;11:33. 
DOI: 10.1186/1471-2202-11-33
[132] Petko J, Justice-Bitner S, Jin J, Wong V, Kittanakom S, Ferraro TN, Stagljar I, Levenson 
R. MOR is not enough: Identification of novel mu-opioid receptor interacting pro-
teins using traditional and modified membrane yeast two-hybrid screens. PLoS One. 
2013;8:e67608. DOI: 10.1371/journal.pone.0067608
[133] Rosemond E, Rossi M, McMillin SM, Scarselli M, Donaldson JG, Wess J. Regulation 
of M₃ muscarinic receptor expression and function by transmembrane protein 147. 
Molecular Pharmacology. 2011;79:251-261. DOI: 10.1124/mol.110.067363
[134] Nakamura Y, Hashimoto T, Ishii J, Kondo A. Dual-color reporter switching system to 
discern dimer formations of G-protein-coupled receptors using Cre/loxP site-specific 
recombination in yeast. Biotechnology and Bioengineering. 2016;113:2178-2190. DOI: 
10.1002/bit.25974
[135] Sokolina K, Kittanakom S, Snider J, Kotlyar M, Maurice P, Gandía J, Benleulmi-
Chaachoua A, Tadagaki K, Oishi A, Wong V, Malty RH, Deineko V, Aoki H, Amin S, 
Yao Z, Morató X, Otasek D, Kobayashi H, Menendez J, Auerbach D, Angers S, Przulj 
N, Bouvier M, Babu M, Ciruela F, Jockers R, Jurisica I, Stagljar I. Systematic protein-
protein interaction mapping for clinically relevant human GPCRs. Molecular Systems 
Biology. 2017;13:918. DOI: 10.15252/msb.20167430
[136] Nakamura Y, Takemoto N, Ishii J, Kondo A. Simultaneous method for analyzing dimer-
ization and signaling of G-protein-coupled receptor in yeast by dual-color reporter sys-
tem. Biotechnology and Bioengineering. 2014;111:586-596. DOI: 10.1002/bit.25125
[137] Lagerström MC, Schiöth HB. Structural diversity of G protein-coupled receptors and 
significance for drug discovery. Nature Reviews Drug Discovery. 2008;7:339-357. DOI: 
10.1038/nrd2518
Biosensing Techniques in Yeast: G-Protein Signaling and Protein-Protein Interaction Assays…
http://dx.doi.org/10.5772/intechopen.76330
47

